BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 10966490)

  • 1. Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.
    Tanji N; Markowitz GS; Fu C; Kislinger T; Taguchi A; Pischetsrieder M; Stern D; Schmidt AM; D'Agati VD
    J Am Soc Nephrol; 2000 Sep; 11(9):1656-1666. PubMed ID: 10966490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between the expression of advanced glycation end-products (AGE) and the receptor for AGE (RAGE) mRNA in diabetic nephropathy.
    Suzuki D; Toyoda M; Yamamoto N; Miyauchi M; Katoh M; Kimura M; Maruyama M; Honma M; Umezono T; Yagame M
    Intern Med; 2006; 45(7):435-41. PubMed ID: 16679697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of tubular epithelial cells in diabetic nephropathy.
    Morcos M; Sayed AA; Bierhaus A; Yard B; Waldherr R; Merz W; Kloeting I; Schleicher E; Mentz S; Abd el Baki RF; Tritschler H; Kasper M; Schwenger V; Hamann A; Dugi KA; Schmidt AM; Stern D; Ziegler R; Haering HU; Andrassy M; van der Woude F; Nawroth PP
    Diabetes; 2002 Dec; 51(12):3532-44. PubMed ID: 12453911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-phenacylthiazolium bromide decreases renal and increases urinary advanced glycation end products excretion without ameliorating diabetic nephropathy in C57BL/6 mice.
    Schwedler SB; Verbeke P; Bakala H; Weiss MF; Vilar J; Depreux P; Fourmaintraux E; Striker LJ; Striker GE
    Diabetes Obes Metab; 2001 Aug; 3(4):230-9. PubMed ID: 11520302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.
    Horie K; Miyata T; Maeda K; Miyata S; Sugiyama S; Sakai H; van Ypersole de Strihou C; Monnier VM; Witztum JL; Kurokawa K
    J Clin Invest; 1997 Dec; 100(12):2995-3004. PubMed ID: 9399945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions.
    Suzuki D; Miyata T; Saotome N; Horie K; Inagi R; Yasuda Y; Uchida K; Izuhara Y; Yagame M; Sakai H; Kurokawa K
    J Am Soc Nephrol; 1999 Apr; 10(4):822-32. PubMed ID: 10203367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy.
    Wendt T; Tanji N; Guo J; Hudson BI; Bierhaus A; Ramasamy R; Arnold B; Nawroth PP; Yan SF; D'Agati V; Schmidt AM
    J Am Soc Nephrol; 2003 May; 14(5):1383-95. PubMed ID: 12707408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation end products and the progressive course of renal disease.
    Heidland A; Sebekova K; Schinzel R
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S100-6. PubMed ID: 11576932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of receptors for advanced glycosylated end-products in renal disease.
    Abel M; Ritthaler U; Zhang Y; Deng Y; Schmidt AM; Greten J; Sernau T; Wahl P; Andrassy K; Ritz E
    Nephrol Dial Transplant; 1995; 10(9):1662-7. PubMed ID: 8559486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of receptors for advanced glycation end-products in occlusive vascular and renal disease.
    Bierhaus A; Ritz E; Nawroth PP
    Nephrol Dial Transplant; 1996; 11 Suppl 5():87-90. PubMed ID: 9044315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation end-products in diabetic nephropathy.
    Sugiyama S; Miyata T; Horie K; Iida Y; Tsuyuki M; Tanaka H; Maeda K
    Nephrol Dial Transplant; 1996; 11 Suppl 5():91-4. PubMed ID: 9044316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.
    Valencia JV; Weldon SC; Quinn D; Kiers GH; DeGroot J; TeKoppele JM; Hughes TE
    Anal Biochem; 2004 Jan; 324(1):68-78. PubMed ID: 14654047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAGE in diabetic nephropathy.
    Yamamoto H; Watanabe T; Yamamoto Y; Yonekura H; Munesue S; Harashima A; Ooe K; Hossain S; Saito H; Murakami N
    Curr Mol Med; 2007 Dec; 7(8):752-7. PubMed ID: 18331233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAGE: a novel target for drug intervention in diabetic vascular disease.
    Hudson BI; Schmidt AM
    Pharm Res; 2004 Jul; 21(7):1079-86. PubMed ID: 15290845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy.
    Forbes JM; Thorpe SR; Thallas-Bonke V; Pete J; Thomas MC; Deemer ER; Bassal S; El-Osta A; Long DM; Panagiotopoulos S; Jerums G; Osicka TM; Cooper ME
    J Am Soc Nephrol; 2005 Aug; 16(8):2363-72. PubMed ID: 15930093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for advanced glycation end products in diminished bone healing in type 1 diabetes.
    Santana RB; Xu L; Chase HB; Amar S; Graves DT; Trackman PC
    Diabetes; 2003 Jun; 52(6):1502-10. PubMed ID: 12765963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.
    Nakamura S; Tachikawa T; Tobita K; Aoyama I; Takayama F; Enomoto A; Niwa T
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S68-71. PubMed ID: 12612956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAGE mRNA expression in the diabetic mouse kidney.
    Ziyadeh FN; Cohen MP; Guo J; Jin Y
    Mol Cell Biochem; 1997 May; 170(1-2):147-52. PubMed ID: 9144329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The AGE-RAGE system and diabetic nephropathy.
    Sakurai S; Yonekura H; Yamamoto Y; Watanabe T; Tanaka N; Li H; Rahman AK; Myint KM; Kim CH; Yamamoto H
    J Am Soc Nephrol; 2003 Aug; 14(8 Suppl 3):S259-63. PubMed ID: 12874443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A severe diabetic nephropathy model with early development of nodule-like lesions induced by megsin overexpression in RAGE/iNOS transgenic mice.
    Inagi R; Yamamoto Y; Nangaku M; Usuda N; Okamato H; Kurokawa K; van Ypersele de Strihou C; Yamamoto H; Miyata T
    Diabetes; 2006 Feb; 55(2):356-66. PubMed ID: 16443768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.